Ex Parte Coleman et al - Page 14


                  Appeal No.  2005-1422                                                           Page 14                   
                  Application No.  09/997,522                                                                               
                  a T7G.  In all, we find no requirement in claim 12 that any particular “common                            
                  structural feature” be present in the claimed polynucleotide variant.8                                    
                         Further, assuming arguendo, claim 12 was limited to T7G receptors, as                              
                  discussed above T7Gs encompass a large genus of receptors, which according                                
                  to appellants’ specification (page 2), “are related to other T7Gs by their seven                          
                  hydrophobic domains which span the plasma membrane and form a bundle of                                   
                  antiparallel α helices.”  However, contrary to appellants’ assertion (Brief, page                         
                  42), there is no evidence on this record that the genus of T7G receptors can be                           
                  defined in terms of the chemical structure of SEQ ID NO:1 and/or SEQ ID NO:2.                             
                  To that end, there is no evidence on this record that the entire genus                                    
                  encompassed by claim 12 can be defined in terms of the chemical structure of                              
                  SEQ ID NO: 1.  In this regard, there is no requirement in claim 12 that the seven                         
                  hydrophobic domains used to characterize T7Gs be retained in the claimed                                  
                  variant.  Accordingly, contrary to appellants’ assertion (Brief, page 43), claim 12                       
                  does “describe a genus which could be characterized as ‘highly variant.’”                                 
                         “A written description of an invention involving a chemical genus, like a                          
                  description of a chemical species, ‘requires a precise definition, such as by                             
                  structure, formula, [or] chemical name,’ of the claimed subject matter sufficient to                      

                                                                                                                            
                  8 In this regard, we disagree with appellants’ assertion (Reply Brief, page 12), “[t]he claimed           
                  polynucleotide variants are described in terms of their common structural features (e.g., differing       
                  from the amino acid sequence of SEQ ID NO:2 by a substitution of one amino acid residue                   
                  and/or an insertion of 1-5 amino acid residues and/or a deletion of 1-5 amino acid residues), and         
                  in terms of other features such as occurrence in nature.”  We note, however, that with the                
                  exception of its “occurrence in nature,” the variant of claim 12, part b does not require any of the      
                  other “common structural features” asserted by appellants.  Regarding the requirement that the            
                  variant occur in nature, we note that numerous polynucleotides are naturally occurring, and               
                  exhibit no common structural features.  There is simply no evidence on this record, or                    
                  requirement in claim 12, that the claimed variant exhibit any “common structural feature” in              
                  common with SEQ ID NO:1.                                                                                  





Page:  Previous  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  Next 

Last modified: November 3, 2007